TargetMol

Levofloxacin

Product Code:
 
TAR-T6567
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T6567-100mg100mg£109.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6567-1mL1 mL * 10 mM (in DMSO)£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Levofloxacin is a broad-spectrum antibiotic topoisomerase II and topoisomerase IV inhibitor, used to treat respiratory, urinary tract, gastrointestinal, and abdominal infections.
CAS:
100986-85-4
Formula:
C18H20FN3O4
Molecular Weight:
361.37
Pathway:
Microbiology/Virology; DNA Damage/DNA Repair
Purity:
0.9831
SMILES:
C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c2n1cc(C(O)=O)c3=O
Target:
Topoisomerase; Antibacterial; Antibiotic

References

Kong Y, Geng Z, Jiang G, et al.Comparison of the in vitro antibacterial activity of ofloxacin, levofloxacin, moxifloxacin, sitafloxacin, finafloxacin, and delafloxacin against Mycobacterium tuberculosis strains isolated in China.Heliyon.2023 Kato M, et al. Antimicrob Agents Chemother,1995, 39(9), 1979-1983. Davis R, et al. Drugs,1994, 47(4), 677-700. Shen X, Zhang W, Peng C, et al. In vitro anti?bacterial activity and network pharmacology analysis of Sanguisorba officinalis L. against Helicobacter pylori infection. Chinese medicine. 2021, 16(1): 1-19. Fu KP, et al. Antimicrob Agents Chemother,1992, 36(4), 860-866. Shen X, Zhang W, Peng C, et al. In vitro anti?bacterial activity and network pharmacology analysis of Sanguisorba officinalis L. against Helicobacter pylori infection[J]. Chinese medicine. 2021, 16(1): 1-19. Mor N, et al. Antimicrob Agents Chemother,1994, 38(5), 1161-1164. Holtom PD, et al. J Orthop Res,2000, 18(5), 721-727. Yan J, Peng C, Chen P, et al. In-vitro anti-Helicobacter pylori activity and preliminary mechanism of action of Canarium album raeusch. Fruit extracts. Journal of Ethnopharmacology. 2021: 114578.